Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initial Feasibility Study to Treat Resectable Pancreatic Cancer With the Permanently Implantable LDR CivaSheet®

NCT03109041 is registered in ClinicalTrials.gov with CivaTech Oncology as lead sponsor.

NCT NCT03109041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03109041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With the Permanently Implantable LDR CivaSheet®
Lead sponsor
CivaTech Oncology
Phase
Phase 1
Overall status
Completed
Start date
September 6, 2017
Completion date
June 30, 2023
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, pancreas cancer